Table 2.
All adverse events by grade and treatment group.
| SAE | Flu-Bu (N = 130) | FCB_(N = 120) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | ALL | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 | ALL | |
| Mucositis | 27 | 67 | 25 | 0 | 0 | 119 | 29 | 67 | 19 | 0 | 0 | 115 |
| VOD/SOS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 3 |
| Elevated Bilirubin | 10 | 25 | 7 | 0 | 0 | 42 | 10 | 32 | 6 | 1 | 0 | 49 |
| PRES | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 3 |
| DAH | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 2 |
| Pneumonitis | 0 | 0 | 5 | 0 | 1 | 6 | 0 | 0 | 3 | 1 | 1 | 5 |
| Hand/Foot Syndrome | 6 | 5 | 0 | 0 | 0 | 11 | 6 | 4 | 1 | 0 | 0 | 11 |
| Infection: Bacterial | 13 | 5 | 11 | 3 | 1 | 33 | 3 | 4 | 21 | 3 | 6 | 37 |
| Infection: Viral | 9 | 55 | 4 | 1 | 2 | 71 | 10 | 33 | 9 | 0 | 3 | 55 |
| Infection: Fungal | 0 | 0 | 2 | 2 | 2 | 6 | 0 | 0 | 4 | 2 | 3 | 9 |
SAE Serious Adverse Events, VOD Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome, PRES Posterior Reversible Encephalopathy Syndrome, DAH diffuse alveolar hemorrhage.